Literature DB >> 24081624

Loeffler's endocarditis with biventricular mural thrombi.

Naseem Eisa1, Khaldoon Shaheen, Abdul Hamid Alraiyes, M Chadi Alraies.   

Abstract

A 42-year-old man presented to clinic with 1-week history of cough, malaise, loss of appetite and fever. Symptoms started acutely with cough and generalised weakness followed by fever, chills, nausea, vomiting and diarrhoea. He has been healthy before with no chronic illnesses. Further workup disclosed, leucocytosis with 87% eosinophilia, bilateral lung infiltrate, deep venous thrombosis, pulmonary embolism and both right and left biventricular mural thrombi. Extensive workup was done and was consistent with hypereosinophilic syndrome, which explained all his clinical findings. The patient was started on high-dose steroids and responded very well with a complete resolution of symptoms over the course of a few weeks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24081624      PMCID: PMC3794100          DOI: 10.1136/bcr-2013-009609

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

2.  Molecular characterization of paediatric idiopathic hypereosinophilia.

Authors:  Maria Cristina Rapanotti; Roberta Caruso; Emanuele Ammatuna; Serena Zaza; Laura Trotta; Mariadomenica Divona; Laura Cicconi; Daria Funaro; Giorgio Federici; Sergio Amadori; Giulio De Rossi; Francesco Lo-Coco
Journal:  Br J Haematol       Date:  2010-10-19       Impact factor: 6.998

Review 3.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

Review 4.  Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature.

Authors:  Jenna C Podjasek; Joseph H Butterfield
Journal:  Leuk Res       Date:  2013-01-16       Impact factor: 3.156

Review 5.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 6.  Clinical overview of hypereosinophilic syndromes.

Authors:  Javed Sheikh; Peter F Weller
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 7.  The hypereosinophilic syndrome revisited.

Authors:  Florence Roufosse; Elie Cogan; Michel Goldman
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.